- Date 4 Apr 2022
On 31 March 2022, both Will Downie and Paul Fry stepped down from their respective roles as Chief Executive Officer and Chief Financial Officer at Vectura. Under their leadership, Vectura [plc] made significant progress towards its transformation, and today Vectura is recognised as, a valued partner in the pharmaceutical industry for the development of inhaled therapeutic products.
Jorge Insuasty, Chief Life Sciences Officer at PMI, paid tribute to Will and Paul and said: “Since joining Vectura, Will and Paul have developed Vectura into a leading inhaled therapeutic products company. The respect and esteem with which Vectura employees hold them is rightly high, and we thank Will and Paul for their leadership and stewardship of the company”
You might also be interested in these articles
A Global Centre for DeepTech Innovation: Cambridge Future Tech Welcomes Japanese Minister of State to The Park
Sun 12 May 2024
Cambridge Science Park
Steaming up Success: ARU student’s path from café to creativity
We recently did a Q&A session with Anglia Ruskin student Soorya Jith, who started his journey as a Barista at the Lakeside Café within the Bradfield Centre on Cambridge Science Park. He has now transitioned to Krank, also located on the Park, as a Junior Graphic Designer.
Sun 21 Apr 2024
Cambridge Science Park
Cambridge Future Tech Expands its Board with the Appointment of Michael Beer and Jem Davies as Non-Executive Directors
Leading DeepTech Venture-Builder Further Strengthens its Unique Position to Cultivate Innovative Technologies with the Addition of Seasoned Industry Professionals
Sun 14 Apr 2024
Cambridge Future Tech
